Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioLineRx (BLRX) Goodwill & Intangibles (2023 - 2025)

Historic Goodwill & Intangibles for BioLineRx (BLRX) over the last 3 years, with Q3 2025 value amounting to $10.4 million.

  • BioLineRx's Goodwill & Intangibles fell 2157.63% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.4 million, marking a year-over-year decrease of 2157.63%. This contributed to the annual value of $10.4 million for FY2024, which is 2965.53% down from last year.
  • Per BioLineRx's latest filing, its Goodwill & Intangibles stood at $10.4 million for Q3 2025, which was down 2157.63% from $10.4 million recorded in Q2 2025.
  • In the past 5 years, BioLineRx's Goodwill & Intangibles ranged from a high of $22.0 million in Q3 2023 and a low of $10.4 million during Q3 2025
  • For the 3-year period, BioLineRx's Goodwill & Intangibles averaged around $14.9 million, with its median value being $13.7 million (2024).
  • Its Goodwill & Intangibles has fluctuated over the past 5 years, first tumbled by 3986.47% in 2024, then tumbled by 2157.63% in 2025.
  • Over the past 3 years, BioLineRx's Goodwill & Intangibles (Quarter) stood at $14.9 million in 2023, then fell by 29.66% to $10.4 million in 2024, then dropped by 0.58% to $10.4 million in 2025.
  • Its Goodwill & Intangibles stands at $10.4 million for Q3 2025, versus $10.4 million for Q2 2025 and $10.4 million for Q1 2025.